These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28109322)

  • 61. [Analysis of differentially expressed proteins in normal cervix, cervical intraepithelial neoplasia and cervical squamous carcinoma tissues].
    Zhao Q; Wu YM; He Y; Wang XL; Chen S; Qian XH; Zhang YX
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):914-20. PubMed ID: 24506961
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma.
    Tripathi SC; Kaur J; Matta A; Gao X; Sun B; Chauhan SS; Thakar A; Shukla NK; Duggal R; Choudhary AR; DattaGupta S; Sharma MC; Ralhan R; Siu KW
    Mod Pathol; 2012 Jan; 25(1):14-25. PubMed ID: 22002576
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differentially expressed proteins among normal cervix, cervical intraepithelial neoplasia and cervical squamous cell carcinoma.
    Zhao Q; He Y; Wang XL; Zhang YX; Wu YM
    Clin Transl Oncol; 2015 Aug; 17(8):620-31. PubMed ID: 25893434
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Nucleolin expression is correlated with carcinogenesis and progression of cervical squamous cell carcinoma].
    Meng GZ; Zi Y; Li HQ; Huang M; Gao T
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Oct; 35(10):1511-4. PubMed ID: 26547353
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cyclooxygenase-2 expression in cervical intraepithelial neoplasia III and squamous cell cervical carcinoma, and its correlation with clinicopathologic variables.
    Dursun P; Yuce K; Usubutun A; Ayhan A
    Int J Gynecol Cancer; 2007; 17(1):164-73. PubMed ID: 17291249
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expression of beclin 1, an autophagy-related protein, in human cervical carcinoma and its clinical significance.
    Cheng HY; Zhang YN; Wu QL; Sun XM; Sun JR; Huang X
    Eur J Gynaecol Oncol; 2012; 33(1):15-20. PubMed ID: 22439399
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reduced expression of DKK3 is associated with adverse clinical outcomes of uterine cervical squamous cell carcinoma.
    Ryu SW; Kim JH; Kim MK; Lee YJ; Park JS; Park HM; Kim DH; Lee SH; Lee EJ
    Int J Gynecol Cancer; 2013 Jan; 23(1):134-40. PubMed ID: 23154266
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Invasive squamous cell carcinoma and cervical intraepithelial neoplasia III of uterine cervix. Morphologic differences other than stromal invasion.
    Leung KM; Chan WY; Hui PK
    Am J Clin Pathol; 1994 Apr; 101(4):508-13. PubMed ID: 7512787
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I].
    Wang R; Li X; Qian M; Niu J; You Z
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):210-5. PubMed ID: 26268412
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer.
    Cao X; Yao J; Jia M; Shen X; Zhang J; Ju S
    J Ovarian Res; 2022 Feb; 15(1):20. PubMed ID: 35115025
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
    Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
    Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Angiogenesis, cell proliferation and apoptosis in progression of cervical neoplasia.
    Lee JS; Kim HS; Jung JJ; Lee MC; Park CS
    Anal Quant Cytol Histol; 2002 Apr; 24(2):103-13. PubMed ID: 12026048
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Galectin-9 expression links to malignant potential of cervical squamous cell carcinoma.
    Liang M; Ueno M; Oomizu S; Arikawa T; Shinonaga R; Zhang S; Yamauchi A; Hirashima M
    J Cancer Res Clin Oncol; 2008 Aug; 134(8):899-907. PubMed ID: 18264727
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer.
    Branca M; Giorgi C; Santini D; Di Bonito L; Ciotti M; Costa S; Benedetto A; Casolati EA; Favalli C; Paba P; Di Bonito P; Mariani L; Syrjänen S; Bonifacio D; Accardi L; Zanconati F; Syrjänen K;
    Am J Clin Pathol; 2005 Jul; 124(1):113-21. PubMed ID: 15923164
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serum vascular endothelial growth factor and serum leptin in patients with cervical cancer.
    Lebrecht A; Ludwig E; Huber A; Klein M; Schneeberger C; Tempfer C; Koelbl H; Hefler L
    Gynecol Oncol; 2002 Apr; 85(1):32-5. PubMed ID: 11925116
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Acylglycerol kinase is over-expressed in early-stage cervical squamous cell cancer and predicts poor prognosis.
    Sun F; Xiong Y; Zhou XH; Li Q; Xiao L; Long P; Li LJ; Cai MY; Wei YX; Ma YL; Yu YH
    Tumour Biol; 2016 May; 37(5):6729-36. PubMed ID: 26662108
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Constitutive activation of nuclear factor κB contributes to cystic fibrosis transmembrane conductance regulator expression and promotes human cervical cancer progression and poor prognosis.
    Wu Z; Peng X; Li J; Zhang Y; Hu L
    Int J Gynecol Cancer; 2013 Jun; 23(5):906-15. PubMed ID: 23640294
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinico-epigenetic combination including quantitative methylation value of DKK3 augments survival prediction of the patient with cervical cancer.
    Kang WS; Cho SB; Park JS; Lee MY; Myung SC; Kim WY; Lee SH; Kim DH; Lee EJ
    J Cancer Res Clin Oncol; 2013 Jan; 139(1):97-106. PubMed ID: 22961207
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
    Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
    Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.